Special, Non-Exclusive, Royalty-Free Intellectual Property License for COVID-19 Research and Development and Commercialization

Industry and academia are collaborating with unprecedented urgency to develop technological solutions in the global fight against the COVID-19 outbreak. UC Berkeley has developed a non-exclusive, royalty-free license template to induce commercial investment in research, development, and commercialization of COVID-19-related life-saving therapeutics and tools.

 

The license is available for inventions that are currently under development and can be implemented if it does not create any conflicting, contractual obligations, and provided that all of the inventors (or authors as applicable) agree that no royalties, fees, or stock equity will be collected from the manufacture, sales, or distribution of products or services that use the IP rights.

 

Contact IPIRA-concierge@berkeley.edu for more information. We welcome your interest and partnership in expediting solutions to this crisis. 

 
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.